VEGFR2-Lytic

General Information


DRACP ID  DRACP01359

Peptide Name   VEGFR2-Lytic

Sequence  ATWLPPRGGGKLlLKlLkkLLKlLKKK

Sequence Length  27

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
OE19 Not available Not available IC50=7.1μM WST-8 assay 72h Patent
T-47D Invasive breast carcinoma of no special type Carcinoma IC50=6.4μM WST-8 assay 72h Patent
BXPC-3 Pancreatic ductal adenocarcinoma Carcinoma IC50=12.2μM WST-8 assay 72h Patent
U-937 Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia Leukemia IC50=3.5μM WST-8 assay 72h Patent
LNCaP Prostate carcinoma Carcinoma IC50=8.9μM WST-8 assay 72h Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  HEK293: IC50>20μM; MRC-5:>20μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  l=D-Leucine; k=D-Lysine

Chiral  Mix



Physicochemical Information


Formula  C118H198N32O19

Absent amino acids  CDEFHIMNQSVY

Common amino acids  L

Mass  283302

Pl  12.1

Basic residues  7

Acidic residues  0

Hydrophobic residues  9

Net charge  7

Boman Index  -939

Hydrophobicity  -20.37

Aliphatic Index  104.81

Half Life 
  /

Extinction Coefficient cystines  5500

Absorbance 280nm  211.54

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US 2011/0319336 A1

Patent Title  Selective anticancer chimeric peptide.

Other Iinformation  Granted Patent Family: 19s / 19ex; Family Jurisdictions: US, JP, EP, WO, CN; Legal Status: Active; Application No: 200913132580; Filed: Dec 3, 2009; Published: Dec 29, 2011; Earliest Priority: Dec 3, 2008; Granted: May 7, 2013

Other Published ID  CN102238965A  EP2370107A2  WO2010064207A2  WO2010064207A3 




DRACP is developed by Dr.Zheng's team.